Stay updated on Niraparib vs Physician's Choice in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib vs Physician's Choice in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib vs Physician's Choice in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study page still displays a 403 Forbidden error. Its footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T19:23:21.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Access to the study record NCT01905592 is blocked by a 403 Forbidden error, removing the study details and locations from the page. Users are presented with a 403 error page instead of the expected study information.
    Difference
    18%
    Check dated 2026-09-22T22:19:20.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.6 to v3.7.0, representing a refreshed version of the page. The exact textual or UI changes are not specified in the provided data.
    Difference
    0.0%
    Check dated 2026-09-15T21:38:13.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added Tel Litwinsky, Israel, 52621 as a new study site and removed Qiryat Krinitzi, Israel, 52621. This updates the study's participating locations in Israel.
    Difference
    0.1%
    Check dated 2026-09-08T20:21:48.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Israel site list updated: Tel Litwinsky (52621) removed and Qiryat Krinitzi (52621) added. Document revision updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-01T19:41:24.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    A new revision tag (v3.6.5) was added, replacing the prior tag (v3.6.4). This represents a small internal update to the page's versioning.
    Difference
    0.0%
    Check dated 2026-08-11T15:34:30.000Z thumbnail image

Stay in the know with updates to Niraparib vs Physician's Choice in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib vs Physician's Choice in BRCA+ Breast Cancer Clinical Trial page.